2024 BioTech Digital Health 
Digital Health Global
FEBRUARY 28, 2024
Time to share my women’s health updates from February 2024: research breakthroughs, clinical trial findings, endometriosis deep dive, and more. Meanwhile, innovations like Hera Biotech’s non-invasive test and Ziwig Biotech’s saliva test offer hope for a quicker diagnosis.
Healthcare IT Today
FEBRUARY 22, 2024
Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
DECEMBER 11, 2024
With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. The closing was preceded by the fulfillment of customary closing conditions. EBITDA margin and Adj.
Healthcare IT Today
DECEMBER 19, 2024
Co-founded by industry leaders Luis Voloch, Mark Jacobstein, and Sahil Sudeach with a background in AI, healthcare, and biotechnologyJimini Health brings together expertise from healthcare and technology to create an evidence-backed, clinician-led mental health model. Originally announced November 19th, 2024
Digital Health Global
JANUARY 24, 2024
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
Healthcare IT Today
OCTOBER 24, 2024
.” Healthcare Experts – the Critical Factor for Success in New Healthcare Products and Services While health tech, tech-enabled services, medical devices, and life sciences are abundant with innovation, the path to success is challenging. Originally announced October 15th, 2024 MDisrupt has raised $6.6
Lloyd Price
FEBRUARY 23, 2025
Doximitys fiscal Q3 2025 results, ending December 31, 2024, underscore this momentum: revenue climbed 25% year-over-year to $168.6 These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that.
Expert insights. Personalized for you.
167 
Let's personalize your content